ehealth digital library

Digital library of
the Tanzania
health
community

cART Prescription Trends in a Prospective HIV Cohort in Rural Tanzania from 2007 to 2011.

Franzeck, F. C., Letang, E., Mwaigomole, G., Jullu, B., Glass, T. R., Nyogea, D., Hatz, C., Tanner, M. and Battegay, M. (2014) cART Prescription Trends in a Prospective HIV Cohort in Rural Tanzania from 2007 to 2011. BMC infectious diseases, 14 (1). p. 90. ISSN 1471-2334

[img]
Preview
PDF
Fabian_Christoph_Franzeck.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (266kB)

Abstract

Since 2010, World Health Organization (WHO) guidelines discourage using stavudine in first-line regimens due to frequent and severe side effects. This study describes the implementation of this recommendation and trends in usage of antiretroviral therapy combinations in a cohort of HIV-positive patients in rural Tanzania. We analyzed longitudinal, prospectively collected clinical data of HIV-1 infected adults initiating antiretroviral therapy within the Kilombero Ulanga Antiretroviral Cohort (KIULARCO) in Ifakara, Tanzania from 2007-2011. This analysis included data of 3008 patients. Median age was 38 (interquartile range [IQR] 31-45) years, 1962 (65.2%) of all subjects were female, and median CD4+ cell count at enrollment was 168 cells/mm3 (IQR 81-273). The percentage of prescriptions containing stavudine in initial regimens fell from a maximum of 75.3% in 2008 to 10.7% in 2011. TDF/FTC/EFV became available in 2009 and was used in 41.9% of patients initiating cART in 2011. An overall on-treatment analysis revealed that d4T/3TC/NVP and AZT/3TC/EFV were the most prescribed combinations in each year, including 2011 (674 [36.5%] and 641 [34.7%] patients, respectively). Of those receiving stavudine in 2011, 659 (89.1%) initiated it before 2011. Initial cART with stavudine declined to low levels according to recommendations but the overall use of stavudine remained substantial, as individuals already on cART containing stavudine were not changed to alternative drugs. Our findings highlight the critical need to exchange stavudine in treatment regimens of patients who initiated therapy in earlier years.

Item Type: Article
Keywords: cART, Regimen, Antiretroviral, Africa, Stavudine, Ulanga, KIULARCO, Kilombero, HIV, AIDS
Subjects: HIV > Surveillance
HIV > Treatment
Divisions: Ifakara Health Institute > Health Systems
Depositing User: Mr Joseph Madata
Date Deposited: 03 Mar 2014 06:37
Last Modified: 03 Mar 2014 06:37
URI: http://ihi.eprints.org/id/eprint/2524

Actions (login required)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics